News Release - Callout Image

 

News Room

This page is designed to provide you with quick and easy access to key information about King Pharmaceuticals. Here you will find an archive of King news releases, information about our company and leaders and how to reach us.
If you cannot find what you’re looking for, please contact our Corporate Affairs department at 908-429-8350.

05/05/2009 King Pharmaceuticals to Present at Bank of America and Merrill Lynch 2009 Health Care Conference
05/01/2009 Excess Oral Doses of Acurox® Tablets are Disliked by Subjects with a History of Opioid Abuse
04/22/2009 King Pharmaceuticals Announces Date for Release of First Quarter 2009 Earnings
03/12/2009 King Pharmaceuticals to Present at Cowen and Company Health Care Conference
03/03/2009 Acurox® Tablets New Drug Application Accepted for Filing With a Priority Review Classification
02/26/2009 King Pharmaceuticals Reports Year-end and Fourth-quarter 2008 Financial Results PDF File - 02-26-20094QEarningsReleaseCompleteFinal.pdf
02/19/2009 King Pharmaceuticals Plans Webcast to Review Financial Results for the Fourth-Quarter and Year-End 2008 and Provide Strategic Update
02/05/2009 King Pharmaceuticals Offers New Dosage Strengths of Avinza® to Provide More Treatment Options for People With Chronic Pain
02/03/2009 King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses
01/30/2009 King Pharmaceuticals Announces Positive Results From A 12-Month Open-Label Safety And Efficacy Study Of Embeda™ Extended Release Capsules

 

pdf icon

Documents marked with this icon are presented in Portable Document Format (PDF) to retain the original format. To view or print this document, you must use the Adobe® Acrobat® Reader®. Acrobat® Reader® is free and available directly from Adobe’s Web site with full installation instructions. You can either view and print this document or save it to your computer’s hard drive to open later. Your method may vary depending on your operating system and browser type.

Get Acrobat

“Adobe” and “the Adobe logo” are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.